Impact of Fc gamma-receptor polymorphisms on the response to rituximab treatment in children and adolescents with mature B cell lymphoma/leukemia
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impact of Fc gamma-receptor polymorphisms on the response to rituximab treatment in children and adolescents with mature B cell lymphoma/leukemia
Authors
Keywords
Lymphoma, Oncology, Rituximab, Fc gamma-receptor, Response
Journal
ANNALS OF HEMATOLOGY
Volume 95, Issue 9, Pages 1503-1512
Publisher
Springer Nature
Online
2016-07-04
DOI
10.1007/s00277-016-2731-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anti-CD20 Therapy Acts via Fc RIIIA to Diminish Responsiveness of Human Natural Killer Cells
- (2015) C. Capuano et al. CANCER RESEARCH
- Mediastinal Burkitt lymphoma in childhood
- (2014) Marta Pillon et al. PEDIATRIC BLOOD & CANCER
- Improved treatment results of children with B-cell non-Hodgkin lymphoma: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group B-NHL03 study
- (2014) Masahito Tsurusawa et al. PEDIATRIC BLOOD & CANCER
- A critical review of the role of Fc gamma receptor polymorphisms in the response to monoclonal antibodies in cancer
- (2013) James D Mellor et al. Journal of Hematology & Oncology
- Effector mechanisms of anti-CD20 monoclonal antibodies in B cell malignancies
- (2012) Marcin Okroj et al. CANCER TREATMENT REVIEWS
- Fc gamma receptor 3a genotype predicts overall survival in follicular lymphoma patients treated on SWOG trials with combined monoclonal antibody plus chemotherapy but not chemotherapy alone
- (2012) D. O. Persky et al. HAEMATOLOGICA
- High reproducible ADCC analysis revealed a competitive relation between ADCC and CDC and differences between FcγRllla polymorphism
- (2012) Yuji Mishima et al. INTERNATIONAL IMMUNOLOGY
- Identification of patients with indolent B cell lymphoma sensitive to rituximab monotherapy
- (2011) Divi Cornec et al. ANNALS OF HEMATOLOGY
- The impact of Fc- receptor polymorphisms in elderly patients with diffuse large B-cell lymphoma treated with CHOP with or without rituximab
- (2011) M. Ahlgrimm et al. BLOOD
- Interindividual Variability of Response to Rituximab: From Biological Origins to Individualized Therapies
- (2011) G. Cartron et al. CLINICAL CANCER RESEARCH
- The H/R FcγRIIA-131 polymorphism and survival in patients with diffuse large B-cell lymphoma (DLBCL) treated with R-CHOP: a study in a genetically mixed population
- (2011) Débora Levy et al. Clinics
- Fc-Gamma-Receptor IIIa Polymorphism and Gene Expression Profile Do Not Predict the Prognosis in Diffuse Large B-cell Lymphoma Treated with R-CHOP Protocol
- (2011) László Váróczy et al. PATHOLOGY & ONCOLOGY RESEARCH
- Effect of FCGR2A and FCGR3A variants on CLL outcome
- (2010) D. Dornan et al. BLOOD
- Phase II Window Study on Rituximab in Newly Diagnosed Pediatric Mature B-Cell Non-Hodgkin's Lymphoma and Burkitt Leukemia
- (2010) Andrea Meinhardt et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-Term Follow-Up of Patients With Follicular Lymphoma Receiving Single-Agent Rituximab at Two Different Schedules in Trial SAKK 35/98
- (2010) Giovanni Martinelli et al. JOURNAL OF CLINICAL ONCOLOGY
- Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B-cell non-Hodgkin’s lymphoma: results of the FAB/LMB 96 international study
- (2008) Mary Gerrard et al. BRITISH JOURNAL OF HAEMATOLOGY
- FcγRIIa polymorphism and clinical response to rituximab in non-Hodgkin lymphoma patients
- (2008) Márcia Paiva et al. CANCER GENETICS AND CYTOGENETICS
- FCGR3A-158V/F polymorphism may correlate with the levels of immunoglobulin in patients with non-Hodgkin’s lymphoma after rituximab treatment as an adjuvant to autologous stem cell transplantation
- (2008) Mitsufumi Nishio et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Lack of prognostic value of FCGR3A-V158F polymorphism in non-Hodgkin's lymphoma
- (2008) N. M. Pennell et al. HAEMATOLOGICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation